Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Polymorphic Post-Transplant Lymphoproliferative Disorder

Known as: Polymorphic B-Cell Lymphoma, Polymorphic PTLD 
A clonal B-cell lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterized by destructive… Expand
National Institutes of Health

Related topics

Related topics

16 relations
Atypical lymphocyteB lymphoblastB-LymphocytesEpstein-Barr Virus Infections
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Mutational landscape of B‐cell post‐transplant lymphoproliferative disorders
It is currently unclear whether post‐transplant diffuse large B‐cell lymphomas (PT‐DLBCL) display a similar genomic landscape as… Expand
2016
2016
Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer
Post-transplant lymphoproliferative disorders (PTLD) are a heterogeneous group of lymphoid neoplasms occurring as a result of… Expand
  • figure 1
  • figure 2
2010
2010
The changing face of post‐transplant lymphoproliferative disease in the era of molecular EBV monitoring
Kerkar N, Morotti RA, Madan RP, Shneider B, Herold BC, Dugan C, Miloh T, Karabicak I, Strauchen JA, Emre S. The changing face of… Expand
Review
2009
Review
2009
Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation
Post-transplant lymphoproliferative disorder (PTLD) is a well recognized and potentially fatal complication after pediatric… Expand
2009
2009
Post-Transplant Lymphoproliferative Disorders: Role of Viral Infection, Genetic Lesions and Antigen Stimulation in the Pathogenesis of the Disease
Post-transplant lymphoproliferative disorders (PTLD) are a life-threatening complication of solid organ transplantation or, more… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2007
Highly Cited
2007
Salvage Chemotherapy for Refractory and Relapsed Posttransplant Lymphoproliferative Disorders (PTLD) After Treatment With Single-Agent Rituximab
Background. Single-agent rituximab has demonstrated encouraging efficacy and tolerability in posttransplant lymphoproliferative… Expand
Review
2006
Review
2006
Post-transplant lymphoproliferative disorders.
Post-transplant lymphoproliferative disorder is the most common malignancy, with the exception of skin cancer, after solid organ… Expand
  • table 1
  • figure 1
2006
2006
PTLD Visualization by FDG‐PET: Improved Detection of Extranodal Localizations
Post-transplant lymphoproliferative disease (PTLD) is a rare, but serious and potentially lethal complication of solid organ… Expand
Review
2004
Review
2004
Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients
Post-transplant lymphoproliferative disorders are mostly Epstein–Barr virus-related, B-cell tumors that develop as a consequence… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
2004
2004
Flow cytometric evaluation of posttransplant B-cell lymphoproliferative disorders.
CONTEXT Posttransplant B-cell lymphoproliferative disorders (PTLDs) constitute a heterogeneous group that includes hyperplastic… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE